Spatial MSC Index for Predicting Anti-PD-1 Efficacy in Esophageal Cancer
Clinical trial NCT07745322 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07745322
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-05-20
- Primary completion
- 2027-12-31
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.